Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Vitis berlandieri de novo whole genome sequencing

PROVIDER: PRJNA886625 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21816449_subreads.fastq.gz	Fastqsanger.gz

Items per page:

1 - 1 of 1

Similar Datasets

Transcription profiling of grapevine cell cultures treated with DIMEB, a resveratrol elicitor

Project description:Analysis od the transcriptome changes of Vitis riparia x Vitis berlandieri culture cells in response to the modified beta-cyclodextrin, DIMEB, a resveratrol inducer. <br>Cell cultures were treated for 6 hours with 50 mM DIMEB (and without, as reference) and then used for Affymetrix Vitis GeneChip v1.0 hybridization. The experiment has been performed in biological triplicates.

2009-11-01 | E-MEXP-2114 | biostudies-arrayexpress

Dnmt1 has de novo activity targeted to transposable elements

Project description:DNA methylation plays a critical role in development, particularly in repressing retrotransposons. The mammalian methylation landscape is dependent on the combined activities of the canonical maintenance enzyme Dnmt1 and the de novo Dnmts, 3a and 3b. Here we demonstrate that Dnmt1 displays de novo methylation activity in vitro and in vivo with specific retrotransposon targeting. We used whole-genome bisulfite and long-read Nanopore sequencing in genetically engineered methylation depleted embryonic stem cells to provide an in-depth assessment and quantification of this activity. Utilizing additional knockout lines and molecular characterization, we show that Dnmt1's de novo methylation activity depends on Uhrf1 and its genomic recruitment overlaps with targets that enrich for Trim28 and H3K9 trimethylation. Our data demonstrate that Dnmt1 can de novo add and maintain DNA methylation, especially at retrotransposons and that this mechanism may provide additional stability for long-term repression and epigenetic propagation throughout development.

2021-06-29 | PXD025736 | Pride

Staphylococcus aureus

Project description:De novo Bacterial whole genome sequencing

| PRJNA768977 | ENA

Adrianichthys oophorus

Project description:Adrianichthys de novo whole genome sequencing

| PRJDB14395 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Vitis cinerea var. helleri x Vitis rupestris

Project description:Vitis berlandieri x Vitis rupestris alternate haplotype genome sequencing

| PRJNA1063483 | ENA

Vitis labrusca x Vitis berlandieri

Project description:Vitis labrusca x Vitis berlandieri overview

| PRJNA1184919 | ENA

Pseudomonas fluorescens

Project description:De Novo whole genome sequencing of Microbes

| PRJNA599521 | ENA

Project description:Hippobosca camelina De novo whole genome sequencing

| PRJNA1134360 | ENA